Stock Scorecard



Stock Summary for Mimedx Group Inc (MDXG) - $7.54 as of 3/31/2025 1:59:51 PM EST

Total Score

15 out of 30

Safety Score

38 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MDXG

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MDXG

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MDXG

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MDXG

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MDXG (38 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for MDXG

Strength Seen in Sarepta Therapeutics ( SRPT ) : Can Its 8.7% Jump Turn into More Strength? 3/20/2025 5:58:00 AM
MIMEDX to Present at TD Cowen 45th Annual Health Care Conference - MiMedx Group ( NASDAQ:MDXG ) 2/27/2025 1:00:00 PM
MiMedx ( MDXG ) Q4 Earnings Meet Estimates 2/26/2025 10:55:00 PM
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers 2/12/2025 12:00:00 PM
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Allurion Technologies ( NYSE:ALUR ) , Aclarion ( NASDAQ:ACON ) 1/27/2025 9:45:00 AM
JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Alvotech ( NASDAQ:ALVO ) , Alumis ( NASDAQ:ALMS ) 1/17/2025 1:25:00 PM
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Alvotech ( NASDAQ:ALVO ) , Beasley Broadcast Group ( NASDAQ:BBGI ) 1/17/2025 10:23:00 AM
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Alvotech ( NASDAQ:ALVO ) , Beasley Broadcast Group ( NASDAQ:BBGI ) 1/17/2025 10:23:00 AM
Poseida Therapeutics, Inc. ( PSTX ) Hits Fresh High: Is There Still Room to Run? 12/13/2024 2:15:00 PM
MIMEDX to Participate in Upcoming Investor Conferences - MiMedx Group ( NASDAQ:MDXG ) 12/4/2024 1:00:00 PM

Financial Details for MDXG

Company Overview

Ticker MDXG
Company Name Mimedx Group Inc
Country USA
Description MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 12/31/2024
Next Earnings Date 4/28/2025

Stock Price History

Last Day Price 7.54
Price 4 Years Ago 6.04
Last Day Price Updated 3/31/2025 1:59:51 PM EST
Last Day Volume 472,215
Average Daily Volume 583,392
52-Week High 10.14
52-Week Low 5.47
Last Price to 52 Week Low 37.84%

Valuation Measures

Trailing PE 27.29
Industry PE 64.12
Sector PE 40.10
5-Year Average PE -34.29
Free Cash Flow Ratio 12.57
Industry Free Cash Flow Ratio 29.26
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 4.10
Total Cash Per Share 0.60
Book Value Per Share Most Recent Quarter 1.31
Price to Book Ratio 5.83
Industry Price to Book Ratio 5.12
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 3.34
Industry Price to Sales Ratio Twelve Trailing Months 4.27
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 147,366,000
Market Capitalization 1,111,139,640
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -86.10%
Annual Earnings Growth 292.83%
Reported EPS 12 Trailing Months 0.28
Reported EPS Past Year 0.31
Reported EPS Prior Year 0.32
Net Income Twelve Trailing Months 88,458,000
Net Income Past Year 58,228,000
Net Income Prior Year -30,197,000
Quarterly Revenue Growth YOY 7.00%
5-Year Revenue Growth -2.59%
Operating Margin Twelve Trailing Months 12.00%

Balance Sheet

Total Cash Most Recent Quarter 88,801,000
Total Cash Past Year 82,000,000
Total Cash Prior Year 65,950,000
Net Cash Position Most Recent Quarter 70,783,000
Net Cash Position Past Year 32,000,000
Long Term Debt Past Year 50,000,000
Long Term Debt Prior Year 50,000,000
Total Debt Most Recent Quarter 18,018,000
Equity to Debt Ratio Past Year 0.74
Equity to Debt Ratio Most Recent Quarter 0.91
Total Stockholder Equity Past Year 142,717,000
Total Stockholder Equity Prior Year -17,988,000
Total Stockholder Equity Most Recent Quarter 181,008,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 50,460,000
Free Cash Flow Per Share Twelve Trailing Months 0.34
Free Cash Flow Past Year 24,788,000
Free Cash Flow Prior Year -19,407,000

Options

Put/Call Ratio 1.07
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.11
MACD Signal -0.11
20-Day Bollinger Lower Band 7.50
20-Day Bollinger Middle Band 8.70
20-Day Bollinger Upper Band 9.90
Beta 1.97
RSI 41.71
50-Day SMA 7.47
150-Day SMA 6.06
200-Day SMA 6.45

System

Modified 3/28/2025 1:44:18 AM EST